Oculus Innovative Sciences to Present at Maxim Group Growth Conference

Download as PDF

PETALUMA, Calif.--(BUSINESS WIRE)--

Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) announced today that the company will be presenting at the Maxim Group Growth Conference to be held September 20, 2007 at the Grand Hyatt Hotel in New York City. The company's president and chief executive officer, Hoji Alimi, is scheduled to present an overview of the company, its clinical programs and most recent quarter on Thursday, September 20 at 3:30 p.m. (EDT) Track 2. For more information on this event please visit http://www.maximgrp.com/growthconf/.

To access a live audio webcast of Mr. Alimi's presentation, please log on to Oculus Innovative Sciences' website at http://ir.oculusis.com/events.cfm approximately 15 minutes prior to the presentation in order to register and download any necessary software. The webcast will be available for one year at this website.

About Oculus

Oculus Innovative Sciences is a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn(R) Technology platform, which is intended to help prevent and treat infections in chronic and acute wounds. The Microcyn Technology platform is a controlled slow-release solution containing active chlorine and other gases resulting in a biocompatible technology to treat a wide range of pathogens, including antibiotic-resistant strains of bacteria, viruses, fungi and spores. The technology has demonstrated wound healing in chronic and acute wounds. It has been commercialized outside of the U.S. for the treatment of infected wounds. It is currently under evaluation for the treatment of mildly infected diabetic ulcers in the U.S.

Oculus' principal operations are in Petaluma, California, and it conducts operations in Europe, Latin America and Japan through its wholly owned subsidiaries, Oculus Innovative Sciences Netherlands B.V., Oculus Technologies of Mexico, S.A. de C.V. and Oculus Japan K.K. Oculus' website is www.oculusis.com.

Source: Oculus Innovative Sciences, Inc.

Released September 19, 2007